DIFFERENTIAL EXPRESSION OF CELL ADHESION MOLECULES ON LUNG CANCER CELL LINES
CANCER
PATIENTS. ZL 1st
Xing
and
Affiliated
P.R.of We have
investigated
IL-2
patients,24
20
normal
target
in
(IL-2
by
the
first
demostrated of
in
IL-2
with
activity:A.lung IL-2 that
in
enhanced in
by
cancer
(@I IL-2 margin
to
or
in
point acquired
effective
way
defences.
The results
between and
or
its
lung
mice
patients blood
disease
were
lymphocytes
patients
or
were
normal
control disease
29.52+13.52;
patients
A:8
vith
SCLC
activity shooed
the
as This
15.04-+7.85;B.Benign
and
for
SCLC
patients
NSCLC after that
al to the expresssion tion of IL-2 production
cy
lung well
chemotherapy.
cancer
(P
in
those the
natural
in
of
24 as
or
C
were was
following
P< lower
markedly pattern
treatment:CR>PR>NC>PD,(rs=0.60,1’<0.05).
secretion than
emphasize of
NSCLC
of
lung
control
chemotherapy
response
thymocytes
Peripheral in
benign
activity
in lesions
cancer
that:U
comparison
O.Ol).@
using cowse
production
32.21f17.14;C.Normal than
M.Rotsch. J.Heymanns. C.Hennig, K.Havemann. Dept. of Internal Medicine, Philipps-University,Marhurg,Germany
activity
pulmonary
bioassay.Fourteen
after
research capable
production
noncancerous
individuals
cells
reexamined
rare
Wang.
China
cancer as
YZ
Hospital,Lanzhou
tumors
increased
by
treatment.Those can
resist
the
a bigger findings operation
immune defences.For IL-2 is centrof cell-mediated immunity, ‘inhibi-
tumors
would to
a or
delineate
strategically subvert
the
very some
host
relationship IL-2 elaborating and anticancer treatment efficasuggest that IL-2 is a good prognostic indicator assay possible as an assisted diagnostic method of
cancer.
also
be
evade
The organization of cells in differentiated organs and tissues is depend on cell-surface interactions with molecules on the surface of other cells and with the extracellular matrix. Small cell lu!~:,cancer cell lines (SCLC) express a number of neurors)rjocrine features which non small cell lung cancer cells (NSCLC) genrally lack. The presence of the neuronal adhesion molecule (NCAM) which occurs in nervous tissues and in neuroendocrine tumors has been demonstrated in SCLC cell lines (FEBS-Letters 267,295,1990). Since the identity of the 140kOa isoform of NCAM with the leucocyte differentiation antigen CD56 expressed on natural killer cells has been shown (J.Exp.Med. 1'!(q2?33.1989) we analysed the expression of CD56 (NHK-1 j an2 (l-INK-l: carbohydrate epitope on NCAM)on 19 lung cancer cell lines (7 SCLC classic type, 3 SCLC variant type and 9 NSCLC) by flow cytometry and immunoblot. All SCLC cell lines but one with a substrate adherent growth showed an intense staining with CD56. the coexpression of CD57 varied with two variant lines being negative. Only one large cell lung cancer line was CD56 positive. In contrast to the SCLC the NSCLC showed a staining with CD54 (ICAM). In SCLC lines expression of CD56 correlates with in vitro growth properties and lack of CO57 in the variant subtype indicates differences in glycosylation
vasive
of NCAM. This might be implicated behavior of these lung tumors.